The independent source for health policy research, polling, and news.
961 - 980 of 1,299 Results
It鈥檚 getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug鈥檚 high price and insurance company efforts to restrict the use of coupons that shield patients from it.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
Dr. Mark McClellan joined Johnson & Johnson鈥檚 board of directors after leaving the FDA, but the connection often isn鈥檛 mentioned in research papers or public events.
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
Purdue Pharma planned an extensive marketing campaign for the launch and promotion of the painkiller OxyContin. Here are Purdue鈥檚 internal budget documents from 1996 to 2002 鈥 files released by the Florida attorney general鈥檚 office 鈥 that detail the company鈥檚 early strategy to sell and expand use of the drug.
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
Sometimes a drug plan鈥檚 copayment is higher than the cash price, and under a little-known federal rule, pharmacists have to tell Medicare beneficiaries that 鈥 but only if they ask.
More health plans are refusing to count the copayment assistance offered by drug makers as part of the patients鈥 deductibles or out-of-pocket limits.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHN鈥檚 Liz Szabo about the May 鈥淏ill of the Month.鈥
The drugmaker agreed to a settlement with the Justice Department over allegations that it funneled copay assistance money through a foundation to Medicare patients.
KHN鈥檚 Sarah Jane Tribble explains the key elements of the Trump blueprint on CBS News鈥 "Red & Blue."
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump鈥檚 proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Last month, U.S. Surgeon General Jerome Adams聽urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
President Donald Trump鈥檚 much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
漏 2026 KFF